생약재를 이용한 고지혈증 치료의 연구 동향 고찰

Study for Trends of Antihyperlipidemic Studies using Herbal Plants

  • 최성환 (대전대학교 한방병원 내과) ;
  • 손창규 (대전대학교 한방병원 내과) ;
  • 김진미 (대전대학교 한방병원 내과) ;
  • 설인찬 (대전대학교 한방병원 내과)
  • Choi, Seong-Hwan (Internal Department of Oriental Medicine College, Dae-Jeon University) ;
  • Son, Chang-Gue (Internal Department of Oriental Medicine College, Dae-Jeon University) ;
  • Kim, Jin-Mi (Internal Department of Oriental Medicine College, Dae-Jeon University) ;
  • Seol, In-Chan (Internal Department of Oriental Medicine College, Dae-Jeon University)
  • 발행 : 2010.09.30

초록

Objective : To summarize and make a reference number of antihyperlipidemic herbal plants worldwide. Method : We surveyed all papers of antihyperlipidemic studies using herbal plants in Pubmed database as "hyperlipidemia AND herb", "hyperlipidemia AND herbal", etc. of Default Tag "Title". The number of papers, the formation of experiments, frequency of herbal plants studies, and main studies were analyzed. Result : Total 178 studies were finally selected. The number of papers were rapidly was increased since 1998. RCT studies were most papers(39.9%). Most studies were about plant sterol or plant stanol studies(78%). 10 papers studied about Herbal plants. Crataegus pinnatifida Bunge, Salvia miltiorrhiza Bunge, Alisma orientale(Sam.) Juz. and so forth were relatively studied much. Conclusion : This study produced an overview of worldwide antihyperlipidemic plants. This result may provide a valuable information for development of Korean herbal medicine against hyperlipidemia in the future.

키워드

참고문헌

  1. Kasper, Braunwald, Fauci, Hauser, Longo, Jameson. Principle of Internal Medicine 16th. Seoul: MIP;2006, p. 2500-01, 2509-12.
  2. Chung HS et al. Well-being Medicine. Seoul: Seoul National University Press; 2007, p. 135-7.
  3. Korea Health Industry Development Institute. Pharmaceutical Industry Analyst Reports in 2008.
  4. Park JS, Park HD, Yun JW, Jung CH, Lee WY, Kim SW. Prevalence of the metabolic syndrome as defined by NCEP-ATP III among the urban Korean population. Korean Journal of Med. 2002;63(3):290-8.
  5. Lee KI, Sohn ES. Development Trend of Hyperlipidemia Treatment Medicine. Seoul: Korea Institute of Science and Technology Information; 2005, p. 7.
  6. Kim CJ, Lee KJ. Hypercholesterolemia; Management of Korean patients in new millennium. Korean Journal of Med. 2007;72(6):580-92.
  7. Kim JW, Han SH, Jeong BJ, Woo SH, Kim BC, Kim YH et al. A case report of diabetic hyperlipidemia in a patient with cerebral infarction treated with Ojeok-san. Korean J. Orient. Int. Med. 2005;26(1):275-80.
  8. Yun BH, Lim CW, Kim KH, Park YJ, Park JH. The clinical study on abnormal liver function patients caused by obesity. Korean J. Orient. Int. Med. 2001;22(4):547-55.
  9. Woo SH, Kim BC, Kim JW, Jeong BJ, Na EJ, Shim HJ et al. A case report of hyperlipidemia and constipation in a patient with cerebral infarction treated with herbal prescription. Korean J. Orient. Int. Med. 2006;27(4):945-51.
  10. Park SE, Hong SH, Sun OK, Seo CW, Min SS, Hong SH. Clinical effect of Pyungjingunbitanggagam -bang on CVA patients with hyperlipidemia. Korean J. Orient. Int. Med. 2006;27(3):561-72.
  11. Chung KH, Choi YS, Kim LD, Kim JY, Jung WS, Moon SK et al. Effects of Chunghyul-dan on serum lipids in patients with hyperlipidemia. Korean J. Orient. Int. Med. 2003;24(3):543-50.
  12. Shin WT, Heo JE, Kim TH, Hong SH, Kwon OS, Kim KT et al. Clinical effect of Dodamtang on hyperlipidemia patients. Korean J. Orient. Int. Med. 2007;fal(1):113-8.
  13. Cater NB. Plant stanol ester: review of cholesterol -lowering efficacy and implications for coronary heart disease risk reduction. Prev Cardiol. 2000 Summer;3(3):121-30. https://doi.org/10.1111/j.1520-037X.2000.80370.x
  14. Jones PJ. Cholesterol-lowering action of plant sterols. Curr Atheroscler Rep. 1999 Nov;1(3) :230-5. https://doi.org/10.1007/s11883-999-0037-3
  15. Elson CE, Dugan LR Jr, Brafzler LJ, Pearson AM. Effect of isoessential fatty acid lipids from animal and plant sources on cholesterol levels in mature male rats. Lipids. 1966 Sep;1(5):322-4. https://doi.org/10.1007/BF02532674
  16. Park WH, Hong MY, Chung KH, Kim HM, Lee YC, Kim CH. Effects of traditional herbal medicine, Hwaotang, on atherosclerosis using the spontaneous familial hypercholesterolemia model, Kurosawa and Kusanagi-hypercholesterolemic rabbits and the venous thrombosis rats. Phytother Res. 2005 Oct;19(10):846-53. https://doi.org/10.1002/ptr.1700
  17. Varady KA, St-Pierre AC, Lamarche B, Jones PJ. Effect of plant sterols and endurance training on LDL particle size and distribution in previously sedentary hypercholesterolemic adults. Eur J Clin Nutr. 2005 Apr;59(4):518-25. https://doi.org/10.1038/sj.ejcn.1602106
  18. Abidi P, Chen W, Kraemer FB, Li H, Liu J. The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms. J Lipid Res. 2006 Oct;47(10):2134-47. https://doi.org/10.1194/jlr.M600195-JLR200
  19. Abidi P, Zhou Y, Jiang JD, Liu J. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine. Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2170-6. https://doi.org/10.1161/01.ATV.0000181761.16341.2b
  20. Ji W, Gong BQ. Hypolipidemic activity and mechanism of purified herbal extract of Salvia miltiorrhiza in hyperlipidemic rats. J Ethnopharmacol. 2008 Sep 26;119(2):291-8. https://doi.org/10.1016/j.jep.2008.07.013
  21. Shrestha S, Freake HC, McGrane MM, Volek JS, Fernandez ML. A combination of psyllium and plant sterols alters lipoprotein metabolism in hypercholesterolemic subjects by modifying the intravascular processing of lipoproteins and increasing LDL uptake. J Nutr. 2007 May;137(5) :1165-70. https://doi.org/10.1093/jn/137.5.1165
  22. Shrestha S, Volek JS, Udani J, Wood RJ, Greene CM, Aggarwal D, Contois JH, Kavoussi B, Fernandez ML. A combination therapy including psyllium and plant sterols lowers LDL cholesterol by modifying lipoprotein metabolism in hypercholesterolemic individuals. J Nutr. 2006 Oct;136(10):2492-7. https://doi.org/10.1093/jn/136.10.2492
  23. Guo AJ, Choi RC, Cheung AW, Li J, Chen IX, Dong TT, Tsim KW, Lau BW. Stimulation of Apolipoprotein A-IV expression in Caco-2/TC7 enterocytes and reduction of triglyceride formation in 3T3-L1 adipocytes by potential anti-obesity Chinese herbal medicines. Chin Med. 2009 Mar;26:4-5.
  24. Bhardwaj PK, Dasgupta DJ, Prashar BS, Kaushal SS. Effective reduction of LDL cholesterol by indigenous plant product. J Indian Med Assoc. 1994 Mar;92(3):80-1.
  25. Cheng BJ, Moritomo A, Yamasaki Y, Wu LX, Inagaki M, Nishimura M, Tanishima K, Poracova J. Preventive effect of traditional herbal formulae against experimental hypercholesterolemia in rats with special reference to blood lipoprotein cholesterol levels. J Ethnopharmacol. 2004 Oct; 94(2-3):275-8. https://doi.org/10.1016/j.jep.2004.05.009
  26. Dou XB, Wo XD, Fan CL. Progress of research in treatment of hyperlipidemia by monomer or compound recipe of Chinese herbal medicine. Chin J Integr Med. 2008 Mar;14(1):71-5. https://doi.org/10.1007/s11655-008-0071-y
  27. Kurokawa M, Masuda Y, Noda M, Usuda M, Takeda S, Hasegawa M, Homma Y, Sugano M. Effects of dressing containing plant sterol on serum cholesterol concentration and the safety evaluation in borderline or mildly hypercholesterolemic Japanese subjects. J Oleo Sci. 2008;57(1):35-45. https://doi.org/10.5650/jos.57.35
  28. Plat J. and Mensink RP. Increased intestinal ABCA1 expression contributes to the decrease in cholesterol absorption after plant stanol consumption. The FASEB Journal. 2002;16 :1248-53. https://doi.org/10.1096/fj.01-0718hyp
  29. Wooltorton E. Bayer pulls cerivastatin (Baycol) from market. CMAJ. 2001 September 4;165(5) :632.